National Health Act 1953 Amendment determination under section 85B price determinations and special patient contributions (No. PB 4 of 2009) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 4 of 2009

Amendment determination under section 85B of the National Health Act 1953

I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under section 85B of the National Health Act 1953.

Dated 2nd JANUARY 2009

DIANA MACDONELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment — price determinations and special patient contributions

1              Commencement  

This instrument commences on 1 February 2009.

2              Amendment of PB 118 of 2008

Schedule 1 amends PB 118 of 2008.

Schedule 1        Amendments

[1]           Schedule 1, item dealing with Clomiphene (Clomid)

omit from the column headed “Claimed Price”:

34.21

and substitute:

26.59

[2]           Schedule 1, item dealing with Codeine with Paracetamol

omit from the column headed “Claimed Price”:

5.17

and substitute:

3.88

[3]           Schedule 1, item dealing with Dexamethasone with Framycetin and Gramicidin

omit from the column headed “Claimed Price”:

3.86

and substitute:

3.78

[4]           Schedule 1, item dealing with Frusemide in the form Tablet 20 mg

omit from the column headed “Claimed Price”:

2.78

and substitute:

1.96

[5]           Schedule 1, item dealing with Frusemide in the form Tablet 40 mg

omit from the column headed “Claimed Price”:

4.95

and substitute:

4.15

[6]           Schedule 1, item dealing with Glibenclamide

omit from the column headed “Claimed Price”:

6.02

and substitute:

5.90

[7]           Schedule 1, item dealing with Glimepiride in the form Tablet 1 mg

omit from the column headed “Claimed Price”:

6.35

and substitute:

4.77

[8]           Schedule 1, item dealing with Glimepiride in the form Tablet 2 mg

omit from the column headed “Claimed Price”:

9.19

and substitute:

6.90

[9]           Schedule 1, item dealing with Glimepiride in the form Tablet 3 mg

omit from the column headed “Claimed Price”:

10.87

and substitute:

8.16

[10]         Schedule 1, item dealing with Glimepiride in the form Tablet 4 mg

omit from the column headed “Claimed Price”:

12.57

and substitute:

9.43

[11]         Schedule 1, item dealing with Ketoprofen

omit from the column headed “Claimed Price”:

13.24

and substitute:

13.72

[12]         Schedule 1, item dealing with Metronidazole in the form Tablet 400 mg

omit from the column headed “Claimed Price”:

6.85

and substitute:

5.14

[13]         Schedule 1, item dealing with Metronidazole in the form Tablet 200 mg

omit from the column headed “Claimed Price”:

4.46

and substitute:

3.34

[14]         Schedule 1, item dealing with Prochlorperazine

omit from the column headed “Claimed Price”:

4.49

and substitute:

5.30

[15]         Schedule 1, item dealing with Roxithromycin in the form Tablet 150 mg

omit from the column headed “Claimed Price”:

9.19

and substitute:

6.90

[16]         Schedule 1, item dealing with Roxithromycin in the form Tablet 300 mg

omit from the column headed “Claimed Price”:

9.19

and substitute:

6.90

[17]         Schedule 1, item dealing with Trandolapril in the form Capsule 1 mg

omit from the columns in the order indicated:

Oral Odrik 28 7.52 9.57

[18]         Schedule 1, item dealing with Trandolapril in the form Capsule 2 mg

omit from the columns in the order indicated:

Oral Odrik 28 8.53 10.58

[19]         Schedule 1, item dealing with Valproic Acid in the form Tablet (enteric coated) containing sodium valproate

200 mg

omit from the column headed “Claimed Price”:

12.85

and substitute:

12.58

[20]         Schedule 1, item dealing with Valproic Acid in the form Tablet (enteric coated) containing sodium valproate

500 mg

omit from the column headed “Claimed Price”:

24.81

and substitute:

24.30